Michael Loberg

No más puestos en curso

Fortuna: 634 399 $ al 30/04/2024

76 años

100 relaciones

Health Technology

Consumer Services

Historial de carrera de Michael Loberg

Antiguos cargos conocidos de Michael Loberg.

Empresas	Cargo	Inicio	Fin
IGM BIOSCIENCES, INC.	Director/Miembro de la Junta	01/09/2015	01/08/2018
	Presidente	01/08/2018	03/10/2023
	Independent Dir/Board Member	-	03/10/2023
ARQULE, INC.	Director/Miembro de la Junta	01/01/2007	01/01/2020
Inotek Pharmaceuticals Corp. Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA.	Director/Miembro de la Junta	03/06/2011	01/07/2014
	Presidente	31/05/2010	03/06/2011
	Independent Dir/Board Member	01/03/2006	01/07/2014
	Presidente	01/03/2006	31/05/2010
AMAG PHARMACEUTICALS, INC.	Director/Miembro de la Junta	15/05/2009	15/05/2009
NETMED, INC.	Presidente	01/01/1997	01/03/2006
NitroMed, Inc. NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA.	Director/Miembro de la Junta	01/09/1997	01/03/2006
	Director Ejecutivo	01/09/1997	01/03/2006
	Presidente	01/09/2003	01/03/2006
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/01/1997	01/01/1997
E.R. Squibb & Sons Research & Development	Director/Miembro de la Junta	01/01/1997	01/01/1997
E.R. Squibb & Sons Research & Development	Corporate Officer/Principal	01/01/1997	01/01/1997
University of Maryland	Corporate Officer/Principal	01/01/1973	01/01/1979
░░ ░░ ░░░░░░ ░ ░░░░ ░░░	░░░░░░░░░░░░░░ ░░░░░░	-	-
░░ ░░ ░░░░░░ ░ ░░░░ ░░░	░░░░░ ░░░░░░░░░░░░ ░░░░░░░	-	-
░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░	-

Formación de Michael Loberg.

Washington University in St. Louis	Doctorate Degree
Trinity College (Connecticut)	Undergraduate Degree

Estadísticas

Internacional

Estados Unidos

Operativa

Director/Board Member	8
President	3
Corporate Officer/Principal	3

Sectorial

Health Technology	9
Consumer Services	4

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas relacionadas

Empresas cotizadas	3
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
NETMED, INC.	Health Technology
IGM BIOSCIENCES, INC.	Health Technology

Empresas privadas	7
ArQule, Inc. ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA.	Health Technology
NitroMed, Inc. NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA.	Health Technology
Inotek Pharmaceuticals Corp. Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA.	Health Technology
Kereos, Inc. Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO.	Health Technology
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.	Health Technology
E. R. Squibb & Sons LLC
E.R. Squibb & Sons Research & Development

Ver las conexiones de la empresa